UPDATED Apr 25, 2024
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSF | US$365.90 | -2.0% | 38.4% | US$3.0t | US$435.01 | PE34.4x | E12.4% | 0.8% | Software | ||
NVD | US$739.80 | -12.7% | n/a | US$2.0t | US$891.37 | PE68.3x | E22.9% | 0.02% | Semiconductors | ||
ABEC | US$132.68 | 0% | n/a | US$2.0t | US$147.13 | PE26.3x | E12.4% | n/a | Media | ||
FB2A | US$463.10 | 0% | 115.1% | US$1.1t | US$549.63 | PE24.5x | E12.2% | 0.5% | Media | ||
NFC | US$522.60 | 0% | n/a | US$243.4b | US$591.62 | PE37.8x | E16.3% | n/a | Media | ||
BY6 | HK$23.89 | 0% | -9.9% | HK$631.7b | HK$34.15 | PE18.2x | E14.6% | 1.6% | Automobiles | ||
MLB1 | US$1,294.20 | 1.3% | 14.1% | US$69.1b | US$1,754.72 | PE72.2x | E26.6% | 0% | Retail | ||
D4S | JP¥29.86 | 5.1% | -3.6% | JP¥9.6t | JP¥33.81 | PE47.9x | E20.9% | 1.2% | Pharmaceuticals & Biotech | ||
RME | US$194.20 | 16.0% | -10.1% | US$26.9b | US$189.12 | PE33.4x | E13.4% | 0.9% | Healthcare | ||
ZAL | €18.45 | 0% | -49.3% | €6.8b | €22.69 | PE81.3x | E28.5% | n/a | Retail | ||
GFT | €28.70 | 0% | -18.4% | €747.7m | €45.88 | PE15.5x | E14.4% | 1.8% | Software | ||
SLYG | лв68.00 | -0.6% | 209.1% | лв1.2b | лв61.68 | PE36.5x | E29.4% | 0.4% | Tech |